Cooper Companies | COO - Ebitda

سعر السهم
60.94
التغيير اليومي
1.33 2.23%
شهريا
-12.27%
سنويا
-25.60%
Q2 التوقعات
58.41




Ebitda تغيير تاريخ
Abbott USD 3.27B 178M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Avanos Medical USD 13M 3M 2025-12
Bausch Health Companies USD 837M 94M 2026-03
Baxter International USD -447M 873M 2025-12
Bayer EUR 4.45B 2.49B 2026-03
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dentsply International USD 129M 6M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 94.78M 20.75M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 5.84B 235M 2025-09
ResMed USD 547.48M 27.46M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Steris USD 394.7M 5M 2025-12
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12